106 related articles for article (PubMed ID: 7349895)
1. Kinetics of cyclophosphamide biotransformation in vivo.
Domeyer BE; Sladek NE
Cancer Res; 1980 Jan; 40(1):174-80. PubMed ID: 7349895
[No Abstract] [Full Text] [Related]
2. Cytotoxic activity relative to 4-hydroxycyclophosphamide and phosphoramide mustard concentrations in the plasma of cyclophosphamide-treated rats.
Powers JF; Sladek NE
Cancer Res; 1983 Mar; 43(3):1101-6. PubMed ID: 6825082
[No Abstract] [Full Text] [Related]
3. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
Struck RF; Alberts DS
Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide and 4-Hydroxycyclophosphamide/aldophosphamide kinetics in patients receiving high-dose cyclophosphamide chemotherapy.
Anderson LW; Chen TL; Colvin OM; Grochow LB; Collins JM; Kennedy MJ; Strong JM
Clin Cancer Res; 1996 Sep; 2(9):1481-7. PubMed ID: 9816324
[TBL] [Abstract][Full Text] [Related]
5. Trapping of DNA-reactive metabolites of therapeutic or carcinogenic agents by carbon-14-labeled synthetic polynucleotides.
Mehta JR; Ludlum DB
Cancer Res; 1982 Aug; 42(8):2996-9. PubMed ID: 7093949
[TBL] [Abstract][Full Text] [Related]
6. The determination of cyclophosphamide and its metabolites in blood plasma as stable trifluoroacetyl derivatives by electron capture chemical ionization gas chromatography/mass spectrometry.
Momerency G; Van Cauwenberghe K; Slee PH; Van Oosterom AT; De Bruijn EA
Biol Mass Spectrom; 1994 Mar; 23(3):149-58. PubMed ID: 8148406
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
8. Cyclophosphamide metabolism in children.
Yule SM; Boddy AV; Cole M; Price L; Wyllie R; Tasso MJ; Pearson AD; Idle JR
Cancer Res; 1995 Feb; 55(4):803-9. PubMed ID: 7850793
[TBL] [Abstract][Full Text] [Related]
9. Cyclophosphamide analogues.
Zon G
Prog Med Chem; 1982; 19():205-46. PubMed ID: 6758039
[No Abstract] [Full Text] [Related]
10. Effect of phenobarbital on plasma levels of cyclophosphamide and its metabolites in the mouse.
Alberts DS; Peng YM; Chen HS; Struck RF
Br J Cancer; 1978 Aug; 38(2):316-24. PubMed ID: 698048
[TBL] [Abstract][Full Text] [Related]
11. The comparative pharmacology of cyclophosphamide and ifosfamide.
Colvin M
Semin Oncol; 1982 Dec; 9(4 Suppl 1):2-7. PubMed ID: 6761865
[No Abstract] [Full Text] [Related]
12. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
Dirven HA; van Ommen B; van Bladeren PJ
Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469
[TBL] [Abstract][Full Text] [Related]
13. Analysis of phosphoramide mustard by reversed-phase ion pair high pressure liquid chromatography.
Hardy RW; Moore MJ; Erlichman C; Soldin SJ
Ther Drug Monit; 1987 Jun; 9(2):221-6. PubMed ID: 3617163
[TBL] [Abstract][Full Text] [Related]
14. Intraneoplastic polymer-based delivery of cyclophosphamide for intratumoral bioconversion by a replicating oncolytic viral vector.
Ichikawa T; Petros WP; Ludeman SM; Fangmeier J; Hochberg FH; Colvin OM; Chiocca EA
Cancer Res; 2001 Feb; 61(3):864-8. PubMed ID: 11221871
[TBL] [Abstract][Full Text] [Related]
15. Analysis of 4-hydroxycyclophosphamide by gas chromatography-mass spectrometry in plasma.
Hong PS; Chan KK
J Chromatogr; 1989 Oct; 495():131-8. PubMed ID: 2613798
[TBL] [Abstract][Full Text] [Related]
16. The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy.
Juma FD; Rogers HJ; Trounce JR
Br J Clin Pharmacol; 1980 Oct; 10(4):327-35. PubMed ID: 7448105
[No Abstract] [Full Text] [Related]
17. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
[TBL] [Abstract][Full Text] [Related]
18. Denaturation of cytochrome P-450 by cyclophosphamide metabolites.
Marinello AJ; Gurtoo HL; Struck RF; Paul B
Biochem Biophys Res Commun; 1978 Aug; 83(4):1347-53. PubMed ID: 697865
[No Abstract] [Full Text] [Related]
19. Clinical pharmacokinetics of cyclophosphamide and metabolites with and without SR-2508.
Chan KK; Hong PS; Tutsch K; Trump DL
Cancer Res; 1994 Dec; 54(24):6421-9. PubMed ID: 7987837
[TBL] [Abstract][Full Text] [Related]
20. Nonlinear pharmacokinetics of cyclophosphamide and 4-hydroxycyclophosphamide/aldophosphamide in patients with metastatic breast cancer receiving high-dose chemotherapy followed by autologous bone marrow transplantation.
Chen TL; Kennedy MJ; Anderson LW; Kiraly SB; Black KC; Colvin OM; Grochow LB
Drug Metab Dispos; 1997 May; 25(5):544-51. PubMed ID: 9152592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
